{"id":6347,"date":"2022-02-14T18:18:23","date_gmt":"2022-02-14T17:18:23","guid":{"rendered":"https:\/\/alpha1-deutschland.org\/?p=6347"},"modified":"2025-03-12T10:56:06","modified_gmt":"2025-03-12T09:56:06","slug":"alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel","status":"publish","type":"post","link":"https:\/\/alpha1-deutschland.org\/en\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel","title":{"rendered":"Alpha1-antitrypsin deficiency-associated liver disease (AATD-LD): A look into the crystal ball"},"content":{"rendered":"<div id=\"fws_6aa7e12c3e3f5\"  data-column-margin=\"default\" data-midnight=\"dark\"  class=\"wpb_row vc_row-fluid vc_row full-width-section\"  style=\"padding-top: 0px; padding-bottom: 0px; \"><div class=\"row-bg-wrap\" data-bg-animation=\"none\" data-bg-animation-delay=\"\" data-bg-overlay=\"false\"><div class=\"inner-wrap row-bg-layer\" ><div class=\"row-bg viewport-desktop\"  style=\"\"><\/div><\/div><\/div><div class=\"row_col_wrap_12 col span_12 dark left\">\n\t<div  class=\"vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone\"  data-padding-pos=\"all\" data-has-bg-color=\"false\" data-bg-color=\"\" data-bg-opacity=\"1\" data-animation=\"\" data-delay=\"0\" >\n\t\t<div class=\"vc_column-inner\" >\n\t\t\t<div class=\"wpb_wrapper\">\n\t\t\t\t<div class=\"vc_separator wpb_content_element vc_separator_align_center vc_sep_width_100 vc_sep_border_width_5 vc_sep_pos_align_center vc_sep_color_grey wpb_content_element vc_separator-has-text\" ><span class=\"vc_sep_holder vc_sep_holder_l\"><span class=\"vc_sep_line\"><\/span><\/span><h4>Author<\/h4><span class=\"vc_sep_holder vc_sep_holder_r\"><span class=\"vc_sep_line\"><\/span><\/span>\n<\/div>\n<div class=\"wpb_text_column wpb_content_element\" >\n\t<p style=\"font-weight: 400;\"><strong>Dr. Marlin Fromme and Prof. Pavel Strnad, Alpha1 Germany eV, as published in <a href=\"https:\/\/alpha1-deutschland.org\/en\/alpha1-journal\/\">Alpha1 Journal 2\/2022<\/a>.<\/strong><\/p>\n<\/div>\n\n\n\n<div class=\"divider-wrap\" data-alignment=\"default\"><div style=\"margin-top: 25px; height: 5px; margin-bottom: 25px;\" data-width=\"100%\" data-animate=\"\" data-animation-delay=\"\" data-color=\"default\" class=\"divider-border\"><\/div><\/div>\n<div class=\"wpb_text_column wpb_content_element\" >\n\t<p><strong>\u201e&quot;The follow-up study now has its first results, which impressively demonstrate the usefulness of the research methods used to date.&quot;\u201c<\/strong><\/p>\n<p>Alpha-1 antitrypsin deficiency-associated liver disease (AATD-LD) is currently on the rise. Positive data on fazirsiran, an siRNA drug, were recently published, and consequently, many are now wondering whether this medication is also suitable for them. To answer this question, we need to be able to look into the future to predict the risk of developing clinically relevant liver disease. Fortunately, we are well-equipped for this, as this was the very question that motivated us to found the Alpha1 Consortium in 2015. Over the years, we have strived to comprehensively characterize the Alpha1 drugs clinically and in the laboratory. Last year, we contacted some of you by phone or mail to check on your progress and to see if any complications had arisen in the meantime.<\/p>\n<p>This so-called longitudinal follow-up study has now yielded its first results, impressively demonstrating the usefulness of the examination methods used to date. The core of our investigations so far has been the measurement of liver stiffness using FibroScan. Initial analyses now show that values &lt; 7.1 kPa can be classified as &quot;not a cause for concern&quot;.<\/p>\n<p>To date, we have been able to assess the course of more than 300 participants with these values for at least one year, and none of these participants experienced a life-threatening liver complication. Since the average follow-up period was almost four years, this result is an important reassurance. In contrast, there were 28 participants with liver stiffness \u2265 15 kPa, and almost half of them developed serious liver complications. Therefore, we would particularly like to ask participants with double-digit liver stiffness values to contact us and discuss treatment options within the framework of the ongoing clinical trials.<\/p>\n<p>At the same time, we would like to ask for your support in these longitudinal studies. We will contact you again by phone or in writing in the coming months and ask you to complete the relevant questionnaires.<\/p>\n<p>Even more important is to learn from test subjects who have developed serious complications, had to go to hospital, or even died in the meantime.<\/p>\n<p>Only with such complete information can we provide you with expert advice and advance the drug trial. Help us gain a clearer view into the crystal ball!<\/p>\n<p>For the liver team<br \/>\nDr. Marlin Fromme and Prof. Pavel Strnad<\/p>\n<\/div>\n\n\n\n\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>","protected":false},"excerpt":{"rendered":"Authors Dr. Marlin Fromme and Prof. Pavel Strnad, Alpha1 Germany e.V., as published in the Alpha1 Journal 2\/2022. \u201eThe follow-up study now has its first results, which demonstrate the usefulness\u2026\u201d.","protected":false},"author":1,"featured_media":6349,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[39],"tags":[],"class_list":["post-6347","post","type-post","status-publish","format-standard","has-post-thumbnail","category-alpha-1-leber"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alpha1-Antitrypsin-Mangel-assoziierte Lebererkrankung (AATD-LD): Ein Blick in die Kristallkugel - Ihr Online Portal f\u00fcr Mitglieder und Interessierte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/alpha1-deutschland.org\/en\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alpha1-Antitrypsin-Mangel-assoziierte Lebererkrankung (AATD-LD): Ein Blick in die Kristallkugel - Ihr Online Portal f\u00fcr Mitglieder und Interessierte\" \/>\n<meta property=\"og:url\" content=\"https:\/\/alpha1-deutschland.org\/en\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel\/\" \/>\n<meta property=\"og:site_name\" content=\"Ihr Online Portal f\u00fcr Mitglieder und Interessierte\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-14T17:18:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-12T09:56:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/alpha1-deutschland.org\/wp-content\/uploads\/2-22-aatd-kristallkugel.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Redaktion Alpha1 Deutschland e.V.\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redaktion Alpha1 Deutschland e.V.\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/alpha1-deutschland.org\\\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/alpha1-deutschland.org\\\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel\"},\"author\":{\"name\":\"Redaktion Alpha1 Deutschland e.V.\",\"@id\":\"https:\\\/\\\/alpha1-deutschland.org\\\/#\\\/schema\\\/person\\\/bbeaebe048b6117849fb55f50616d631\"},\"headline\":\"Alpha1-Antitrypsin-Mangel-assoziierte Lebererkrankung (AATD-LD): Ein Blick in die Kristallkugel\",\"datePublished\":\"2022-02-14T17:18:23+00:00\",\"dateModified\":\"2025-03-12T09:56:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/alpha1-deutschland.org\\\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel\"},\"wordCount\":635,\"image\":{\"@id\":\"https:\\\/\\\/alpha1-deutschland.org\\\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/alpha1-deutschland.org\\\/wp-content\\\/uploads\\\/2-22-aatd-kristallkugel.jpg\",\"articleSection\":[\"Alpha-1 &amp; Leber\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/alpha1-deutschland.org\\\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel\",\"url\":\"https:\\\/\\\/alpha1-deutschland.org\\\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel\",\"name\":\"Alpha1-Antitrypsin-Mangel-assoziierte Lebererkrankung (AATD-LD): Ein Blick in die Kristallkugel - Ihr Online Portal f\u00fcr Mitglieder und Interessierte\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/alpha1-deutschland.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/alpha1-deutschland.org\\\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/alpha1-deutschland.org\\\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/alpha1-deutschland.org\\\/wp-content\\\/uploads\\\/2-22-aatd-kristallkugel.jpg\",\"datePublished\":\"2022-02-14T17:18:23+00:00\",\"dateModified\":\"2025-03-12T09:56:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/alpha1-deutschland.org\\\/#\\\/schema\\\/person\\\/bbeaebe048b6117849fb55f50616d631\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/alpha1-deutschland.org\\\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/alpha1-deutschland.org\\\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/alpha1-deutschland.org\\\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel#primaryimage\",\"url\":\"https:\\\/\\\/alpha1-deutschland.org\\\/wp-content\\\/uploads\\\/2-22-aatd-kristallkugel.jpg\",\"contentUrl\":\"https:\\\/\\\/alpha1-deutschland.org\\\/wp-content\\\/uploads\\\/2-22-aatd-kristallkugel.jpg\",\"width\":1920,\"height\":1080,\"caption\":\"Frau h\u00e4lt eine Kristallkugel in der Hand\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/alpha1-deutschland.org\\\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/alpha1-deutschland.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alpha1-Antitrypsin-Mangel-assoziierte Lebererkrankung (AATD-LD): Ein Blick in die Kristallkugel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/alpha1-deutschland.org\\\/#website\",\"url\":\"https:\\\/\\\/alpha1-deutschland.org\\\/\",\"name\":\"Ihr Online Portal f\u00fcr Mitglieder und Interessierte\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/alpha1-deutschland.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/alpha1-deutschland.org\\\/#\\\/schema\\\/person\\\/bbeaebe048b6117849fb55f50616d631\",\"name\":\"Redaktion Alpha1 Deutschland e.V.\",\"sameAs\":[\"https:\\\/\\\/alpha1-deutschland.org\\\/\",\"https:\\\/\\\/www.instagram.com\\\/alpha1deutschland\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/marion-wilkens-1b71b6a4\\\/?originalSubdomain=de\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCkcwpGZWn3cQIXp931xMqbA\"],\"url\":\"https:\\\/\\\/alpha1-deutschland.org\\\/en\\\/author\\\/admin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alpha1-Antitrypsin Deficiency-Associated Liver Disease (AATD-LD): A Look into the Crystal Ball - Your Online Portal for Members and Interested Parties","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/alpha1-deutschland.org\/en\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel\/","og_locale":"en_GB","og_type":"article","og_title":"Alpha1-Antitrypsin-Mangel-assoziierte Lebererkrankung (AATD-LD): Ein Blick in die Kristallkugel - Ihr Online Portal f\u00fcr Mitglieder und Interessierte","og_url":"https:\/\/alpha1-deutschland.org\/en\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel\/","og_site_name":"Ihr Online Portal f\u00fcr Mitglieder und Interessierte","article_published_time":"2022-02-14T17:18:23+00:00","article_modified_time":"2025-03-12T09:56:06+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/alpha1-deutschland.org\/wp-content\/uploads\/2-22-aatd-kristallkugel.jpg","type":"image\/jpeg"}],"author":"Redaktion Alpha1 Deutschland e.V.","twitter_misc":{"Written by":"Redaktion Alpha1 Deutschland e.V.","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/alpha1-deutschland.org\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel#article","isPartOf":{"@id":"https:\/\/alpha1-deutschland.org\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel"},"author":{"name":"Redaktion Alpha1 Deutschland e.V.","@id":"https:\/\/alpha1-deutschland.org\/#\/schema\/person\/bbeaebe048b6117849fb55f50616d631"},"headline":"Alpha1-Antitrypsin-Mangel-assoziierte Lebererkrankung (AATD-LD): Ein Blick in die Kristallkugel","datePublished":"2022-02-14T17:18:23+00:00","dateModified":"2025-03-12T09:56:06+00:00","mainEntityOfPage":{"@id":"https:\/\/alpha1-deutschland.org\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel"},"wordCount":635,"image":{"@id":"https:\/\/alpha1-deutschland.org\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel#primaryimage"},"thumbnailUrl":"https:\/\/alpha1-deutschland.org\/wp-content\/uploads\/2-22-aatd-kristallkugel.jpg","articleSection":["Alpha-1 &amp; Leber"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/alpha1-deutschland.org\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel","url":"https:\/\/alpha1-deutschland.org\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel","name":"Alpha1-Antitrypsin Deficiency-Associated Liver Disease (AATD-LD): A Look into the Crystal Ball - Your Online Portal for Members and Interested Parties","isPartOf":{"@id":"https:\/\/alpha1-deutschland.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/alpha1-deutschland.org\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel#primaryimage"},"image":{"@id":"https:\/\/alpha1-deutschland.org\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel#primaryimage"},"thumbnailUrl":"https:\/\/alpha1-deutschland.org\/wp-content\/uploads\/2-22-aatd-kristallkugel.jpg","datePublished":"2022-02-14T17:18:23+00:00","dateModified":"2025-03-12T09:56:06+00:00","author":{"@id":"https:\/\/alpha1-deutschland.org\/#\/schema\/person\/bbeaebe048b6117849fb55f50616d631"},"breadcrumb":{"@id":"https:\/\/alpha1-deutschland.org\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/alpha1-deutschland.org\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/alpha1-deutschland.org\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel#primaryimage","url":"https:\/\/alpha1-deutschland.org\/wp-content\/uploads\/2-22-aatd-kristallkugel.jpg","contentUrl":"https:\/\/alpha1-deutschland.org\/wp-content\/uploads\/2-22-aatd-kristallkugel.jpg","width":1920,"height":1080,"caption":"Frau h\u00e4lt eine Kristallkugel in der Hand"},{"@type":"BreadcrumbList","@id":"https:\/\/alpha1-deutschland.org\/alpha1-antitrypsin-mangel-assoziierte-lebererkrankung-aatd-ld-ein-blick-in-die-kristallkugel#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/alpha1-deutschland.org\/"},{"@type":"ListItem","position":2,"name":"Alpha1-Antitrypsin-Mangel-assoziierte Lebererkrankung (AATD-LD): Ein Blick in die Kristallkugel"}]},{"@type":"WebSite","@id":"https:\/\/alpha1-deutschland.org\/#website","url":"https:\/\/alpha1-deutschland.org\/","name":"Your online portal for members and interested parties","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/alpha1-deutschland.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/alpha1-deutschland.org\/#\/schema\/person\/bbeaebe048b6117849fb55f50616d631","name":"Editorial team Alpha1 Germany eV.","sameAs":["https:\/\/alpha1-deutschland.org\/","https:\/\/www.instagram.com\/alpha1deutschland\/","https:\/\/www.linkedin.com\/in\/marion-wilkens-1b71b6a4\/?originalSubdomain=de","https:\/\/www.youtube.com\/channel\/UCkcwpGZWn3cQIXp931xMqbA"],"url":"https:\/\/alpha1-deutschland.org\/en\/author\/admin"}]}},"_links":{"self":[{"href":"https:\/\/alpha1-deutschland.org\/en\/wp-json\/wp\/v2\/posts\/6347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alpha1-deutschland.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alpha1-deutschland.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alpha1-deutschland.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/alpha1-deutschland.org\/en\/wp-json\/wp\/v2\/comments?post=6347"}],"version-history":[{"count":0,"href":"https:\/\/alpha1-deutschland.org\/en\/wp-json\/wp\/v2\/posts\/6347\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alpha1-deutschland.org\/en\/wp-json\/wp\/v2\/media\/6349"}],"wp:attachment":[{"href":"https:\/\/alpha1-deutschland.org\/en\/wp-json\/wp\/v2\/media?parent=6347"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alpha1-deutschland.org\/en\/wp-json\/wp\/v2\/categories?post=6347"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alpha1-deutschland.org\/en\/wp-json\/wp\/v2\/tags?post=6347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}